Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Archer

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
Journal of Women'S Health (2002)|April 9, 2016
Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 TrialsSebastian Mirkin, JoAnn V Pinkerton, Risa Kagan, et al.
Menopause (New York, N.Y.)|June 24, 2009
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosisJoAnn V Pinkerton, David F Archer, Wulf H Utian, et al.
Maturitas|April 3, 2017
A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data reviewJames A Simon, David F Archer, Ginger D Constantine, et al.
Maturitas|May 2, 2026
Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled studyTommaso Simoncini, Céline Bouchard, Marie Cloes, et al.
Obstetrics and Gynecology|August 8, 2013
Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptiveDavid F Archer, Steven T Nakajima, Allan T Sawyer, et al.
Menopause (New York, N.Y.)|July 31, 2025
Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapyFrank Z Stanczyk, Jane L Yang, Herjan J T Coelingh Bennink, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2006
Endometrial effects of tiboloneDavid F Archer, Susan Hendrix, J Chris Gallagher, et al.
Contraception|June 5, 2016
Assessment of the vaginal residence time of biomarkers of semen exposureAndrea Thurman, Terry Jacot, Johan Melendez, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2019
Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory WomenDavid F Archer, Juki Ng, Kristof Chwalisz, et al.
Menopause (New York, N.Y.)|December 7, 2016
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophyGinger D Constantine, James A Simon, James H Pickar, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Journal of Women'S Health (2002)|April 9, 2016
Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 TrialsSebastian Mirkin, JoAnn V Pinkerton, Risa Kagan, et al.
Menopause (New York, N.Y.)|June 24, 2009
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosisJoAnn V Pinkerton, David F Archer, Wulf H Utian, et al.
Maturitas|April 3, 2017
A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data reviewJames A Simon, David F Archer, Ginger D Constantine, et al.
Maturitas|May 2, 2026
Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled studyTommaso Simoncini, Céline Bouchard, Marie Cloes, et al.
Obstetrics and Gynecology|August 8, 2013
Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptiveDavid F Archer, Steven T Nakajima, Allan T Sawyer, et al.
Menopause (New York, N.Y.)|July 31, 2025
Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapyFrank Z Stanczyk, Jane L Yang, Herjan J T Coelingh Bennink, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2006
Endometrial effects of tiboloneDavid F Archer, Susan Hendrix, J Chris Gallagher, et al.
Contraception|June 5, 2016
Assessment of the vaginal residence time of biomarkers of semen exposureAndrea Thurman, Terry Jacot, Johan Melendez, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2019
Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory WomenDavid F Archer, Juki Ng, Kristof Chwalisz, et al.
Menopause (New York, N.Y.)|December 7, 2016
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophyGinger D Constantine, James A Simon, James H Pickar, et al.
Pageof 18